Testing a new weight-loss medicine in adults with overweight or obesity
Part of Hormones & metabolism clinical trials.
This study tests a new medication called petrelintide to see how well it helps people lose weight and improve their health. It's for adults with overweight or obesity who have struggled to lose weight with diet alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition like high blood pressure or high cholesterol.
- You have tried to lose weight by dieting at least once, but it didn't work well enough.
- You do not have diabetes (type 1 or type 2), and your blood sugar is below the diabetes range.
- You have never taken petrelintide or any other amylin analog medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called petrelintide to help people with overweight or obesity and heart disease lose weight. It may offer a new way to manage weight and improve heart health.
This study tests a new combination of two medicines, petrelintide and enicepatide, given as a shot to help with weight loss in people who are overweight or have obesity. The goal is to find the best dose and see if it works well and is safe.
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Hear when a new Obesity or Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.